BioInfra Life Sciences Signs Comprehensive Cooperation MOU with Oracle Medical Group
[Asia Economy Reporter Hyunseok Yoo] Bioinfra Life Sciences announced on the 8th that it has agreed to comprehensively cooperate with Oracle Medical Group on joint research on skin drug delivery technology, as well as the development, distribution, and sales of products.
Bioinfra Life Sciences is a company that uniquely attempts the convergence of biomarker discovery and bioinformatics technology, which are core technologies in the bio and medical fields, and possesses world-class cancer pre-screening technology (I-Finder). In addition, it is prominent in the fields of microbubbles and ultrasound, which are skin drug delivery technologies.
In particular, it has technology that maximizes the absorption of active ingredients in cosmetics or drugs through ultrasound-responsive microbubbles. Utilizing this, it launched a cosmetics brand called SONOSKIN in December last year.
Bioinfra plans to jointly research and develop functional cosmetics capable of targeted drug delivery and ultrasound devices by combining skin drug delivery technology with Oracle Medical Group, which possesses abundant cosmetic data and device manufacturing know-how.
Chairman Youngwoo Noh of Oracle Medical Group said, “We especially look forward to collaborating with ‘Dr. Oracle,’ the cosmetic brand of Oracle Dermatology. With the slogan ‘Healthy Breathing Skin,’ all products have completed dermatological clinical trials and have been highly evaluated for specializing in solutions for problematic skin. Through this collaboration with Bioinfra, if the absorption of active ingredients in cosmetics is maximized, it will further highlight these advantages.”
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Bioinfra CEO Deokyun Lee emphasized, “If we cooperate with Tentec (Oracle Medical Group), which developed Wonsera and Tenhigh that have recently made a big impact in beauty devices, and create synergy in various fields, it will greatly benefit both companies, so we will do our best to cooperate. Going forward, we will apply skin drug delivery technology not only to the beauty industry but also to therapeutic fields, showing advanced results in the commercialization of the technology.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
